Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| RA25035163 -01A 1 | Other Grant/Funding Number | University of California, San Francisco | |
| 5P30AI042853-18 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | NIH |
Not provided
Not provided
Not provided
Not provided
The objective of this proposal is to develop an optimal testing strategy for HCV and HIV in high prevalence settings, such as detoxification centers with a large proportion of young injection drug users. The latest venipuncture testing will be compared to rapid finger stick testing for HCV and HIV. Outcomes for each strategy among individuals admitted at a short-term drug detoxification center will be determined.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Rapid finger stick | Experimental | HIV and HCV testing through rapid finger stick. Behavioral questionnaires will also be administered. |
|
| Standard venipuncture | Experimental | HIV and HCV testing through venipuncture. Behavioral questionnaires will also be administered. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Questionnaire | Behavioral | Behavioral questionnaires |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants who receive HCV test results | The number of participants who receive HCV test results by the time they are discharged from the detoxification center | within 5 days (by the time of discharge from the detoxification center) |
| Number of participants who receive HIV test results | The number of participants who receive HIV test results by the time they are discharged from the detoxification center | within 5 days (by the time of discharge from the detoxification center) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants who link to HCV care | The number of participants who are seen for an HCV visit | by three months |
| Number of participants who have HCV RNA testing | The number of participants who have HCV RNA testing performed |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sabrina Assoumou, MD, MPH | Boston Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boston Medical Center | Boston | Massachusetts | 02118 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33751315 | Derived | Assoumou SA, Paniagua SM, Gonzalez P, Wang J, Beckwith CG, White LF, Taylor JL, Coogan K, Samet JH, Linas BP. HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges. AIDS Behav. 2021 Aug;25(8):2591-2598. doi: 10.1007/s10461-021-03220-0. Epub 2021 Mar 22. | |
| 32877557 | Derived | Assoumou SA, Paniagua SM, Linas BP, Wang J, Samet JH, Hall J, White LF, Beckwith CG. Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial. J Infect Dis. 2020 Sep 2;222(Suppl 5):S376-S383. doi: 10.1093/infdis/jiaa162. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006526 | Hepatitis C |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D006525 | Hepatitis, Viral, Human |
Not provided
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| D018962 | Phlebotomy |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Rapid finger stick | Procedure | HIV and HCV testing through rapid finger stick |
|
| Venipuncture | Procedure | HIV and HCV testing through venipuncture |
|
| by three months |
| Number of participants who have fibrosis staging performed | The number participants who have fibrosis staging performed | by three months |
| Number of participants who have HCV treatment initiated | The number participants who have HCV treatment initiated | by six months |
| Number of participants who reach sustained virologic response | The number participants who reach sustained virologic response | by twelve months |
| Number of participants who link to HIV care | The number participants who are seen for an HIV visit | by 3 months |
| Number of participants who HIV RNA testing | The number participants who have HIV RNA testing | by 3 months |
| Number of participants who have CD4 testing | The number participants who have CD4 testing | by 3 months |
| Number of participants who have antiretroviral treatment initiated | The number participants who initiated antiretroviral treatment | by 3 months |
| Number of participants who achieve HIV viral suppression | The number participants who achieve HIV viral suppression | by 6 months |
| D014777 |
| Virus Diseases |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D006505 | Hepatitis |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
| D001800 | Blood Specimen Collection |
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D011677 | Punctures |
| D013812 | Therapeutics |
| D013514 | Surgical Procedures, Operative |